$2.24 (5.66%)

Volume: 773.86k

Closed: Dec 02, 2022

Hollow Logo Score: 6.701

GlycoMimetics Stock Forecast

$2.24 (5.66%)

Volume: 773.86k

Closed: Dec 02, 2022

Score Hollow Logo 6.701

GlycoMimetics Stock Statistics NASDAQ:GLYC

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-10-27 - 2022-12-02 BUY 213.36
2022-10-05 - 2022-10-27 SELL 12.04
2022-10-04 - 2022-10-05 HOLD -0.297
2022-09-15 - 2022-10-04 SELL -6.71
2022-09-14 - 2022-09-15 HOLD -6.08

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT